Exploring the Therapeutic Potential of Chalcones in Alzheimer's Disease: Mechanistic Insights and SAR Perspectives.
Overall, chalcone-based MTDLs provide a rational framework for the development of next-generation anti-Alzheimer agents, highlighting the effects of hydroxylation, methoxylation, halogenation, halogenation, and heterocyclic hybridization on biological activity.